HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Estee Lauder Makes Tom Ford Beauty Entirely Its Own In Deal Valued At $2.8Bn

Executive Summary

Estee Lauder’s agreement values Tom Ford Beauty and its trademarks at $2.8bn. Acquisition will “fortify" growth plans for the brand and help to fuel long-term luxury beauty momentum, says CEO Fabrizio Freda.

You may also be interested in...

Lauder Lowers FY23 Outlook On ‘Temporary Pause’ In China, Tightening Of US Inventory

Estee Lauder Companies says fiscal 2023 second-quarter sales will decline high double digits due to ongoing COVID-19 restrictions in China, tightening inventory by some US retailers, and a strong US dollar. The firm expects improvement in the back half of the year, but has adjusted full-year guidance.

Estee Lauder Companies Signals Growing Luxury Appetite, Possible M&A On Horizon

ELC’s Guillaume Jesel has been named president of global brands overseeing Tom Ford Beauty and Balmain Beauty, the latter targeted for launch in fall 2024 under a licensing agreement with the French fashion house announced on 26 September. Jesel also will head up luxury business development with a “key role in prospective acquisitions and investment strategy.”

Estee Lauder Companies Navigating Bumpy Stretch, Expects Smoother Sailing In FY 2023 Second Half

The Estee Lauder Companies recorded a sales decline of 10% in the fiscal 2022 fourth quarter, generally in line with revised guidance in May as new China lockdowns were impacting its business. Challenges in China and fragrance license terminations are expected to weigh heavily on fiscal 2023 first-quarter results as well, with improvements in Q2 and, ultimately, 7% to 9% organic growth for the year.

Related Content


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts